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Background: Among the characteristics of acute respiratory distress syndrome (ARDS) is edema formation and its
resolution depends on pneumocyte Na/K-ATPase activity. Increased concentration of oleic acid (OA) in plasma
induces lung injury by targeting Na/K-ATPase and, thus, interfering in sodium transport.
Findings: Presently, we adapted a radioactivity-free assay to detect Na/K-ATPase activity in perfused lung mice,
comparing the inhibitory effect of ouabain and OA. We managed to perfuse only the lung, avoiding the systemic loss
of rubidium. Rb+ incorporation into lung was measured by inductively coupled plasma optical emission spectrometry
(ICP OES) technique, after lung tissue digestion. Na/K-ATPase activity was the difference between Rb+ incorporation
with or without ouabain. Lung Na/K-ATPase was completely inhibited by perfusion with ouabain. However, OA caused
a partial inhibition.
Conclusions: In the present work the amount of incorporated Rb+ was greater than seen in our previous report,
showing that the present technique is trustworthy. This new proposed assay may allow researchers to study the
importance of Na/K-ATPase activity in lung pathophysiology.
Keywords: Lung, Na/K-ATPase, Inductively coupled plasma optical emission spectrometerBackground
The first description of acute respiratory distress syn-
drome (ARDS) appeared in 1967 [1]. One of the hallmarks
of ARDS is increased alveolar capillary permeability lead-
ing to an interstitial and alveolar edema [2,3]. The reso-
lution of pulmonary edema and of lung inflammation are
relevant factors for ARDS outcome [4]. Fluid management
is one of the most important measures impacting ARDS,
and a dynamic monitoring of the lung fluid balance seems
to influence the clinical prognosis [5]. The removal of al-
veolar edema depends on the transport of salt and water
across the alveolar epithelium into the lung interstitium
via the basolaterally located Na/K-ATPase [6-8], which in
turn drives the passive water flow toward the capillary net
through the aquaporins [8].* Correspondence: cassianofg@gmail.com
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this article, unless otherwise stated.Na/K-ATPase assay methods based on the incorpor-
ation of Rb+ by cultured cells [9], as well as the measure-
ment of Rb+ efflux in the study of ion channels [10]
have been described. The use of the non-radioactive Rb+
isotope as a K+ substitute avoids the manipulation of
radioactive material. Rubidium, an element not found in
biological systems, may be also measured by the atomic
absorption spectrometry method.
We considered important to test the effect of the Na/
K-ATPase inhibitors in a perfused lung model, which
would allow the evaluation of the efficacy of these inhib-
itors in the intact organ.
As a first step, we propose a method to assay the Na/
K-ATPase activity in absence or presence of ouabain and
oleic acid (OA). In a previous report, we had developed
a method for measuring Na/K-ATPase activity in intact
guinea pig livers, based on the measurement of the up-
take of non-radioactive Rb+ during in situ perfusion in the
absence of K+ in the perfusion medium [11]. Differently
now, we compared Na/K-ATPase inhibition by ouabain, asee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted
ium, provided the original work is properly credited. The Creative Commons
ivecommons.org/publicdomain/zero/1.0/) applies to the data made available in
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also known to induce lung injury in mice lung [12-14].
OA targets this enzyme in vitro [15] and in vivo leading to
lung injury [16,17]. OA levels are elevated in pathological
conditions such as severe leptospirosis [18] and sepsis
[19], diseases evolving to ARDS.
In conclusion, in the present report we compared the
inhibition caused by ouabain to that produced by OA in
an in vivo perfused lung mice model.
Findings
Initially we defined the ideal perfusion flow rate based
on our previous work with guinea pig liver, in which the
ideal flow rate was 3 mL/min. We also defined a short
rinsing period (5 min) because it was proved effective
for efficient rinsing [11]. Besides, in vivo Rb+ quantifica-
tion in mice lung showed a decrease of lung Na/K-
ATPase activity observed 30 min after a single shot of
KCl free-Hank’s containing ouabain or OA [16]. In the
present work, we choose the time of 15 min of perfusion
for two reasons: i) in 15 min, ouabain inhibition could
already be detected; ii) mice lung is smaller than guinea
pig liver, being quickly perfused with the same flow rate.
A scheme of in situ perfusion is showed in Figure 1. Na/K
ATPase activity was almost completely blocked by 1 mM
ouabain in guinea pig liver [11]. Therefore, in the present
work, we also used ouabain 1 mM to show a marked
inhibition of rubidium incorporation in mice lung
(Figure 2A).Figure 1 Experimental scheme: H – heart, L – lung; ICP-OES - InductivOleic acid is used to induce lung injury [17] and it is
associated to increased mortality and complication in
patients with high levels of this free fatty acid in
blood. OA also targets Na/K-ATPase [20-22]. Previous
results from our group in in vitro experiments showed
Na/K-ATPase inhibition near 58% by OA [21]. Our
present data show that the Na/K-ATPase inhibition by
OA was approximately the half as compared to ouabain,
as assessed by our Rb+ incorporation assay (Figure 2B).
Discussion
After Rb+ incorporation, a short rinse with saline ap-
peared to remove the perfusion medium from the vascu-
lar space efficiently. In guinea pig liver it would take less
than one minute to change all the intravascular liquid at a
perfusion rate of 3 ml/min. Assuming that mice lung is a
lot less heavy (weighing 200 mg – 350 mg), most of Rb+
would be removed from lung vascular system after 5 min.
Our previous work with liver showed a direct propor-
tionality between ouabain-sensitive Rb+ uptake and incuba-
tion time up to 60 min, evidencing that ATP concentration
in the tissue remained at acceptable levels for the enzyme
function [11]. We perfused during a shorter period and
it is worth to mention that the enzyme was not short of
ATP. We assume that the ouabain dose completely
blocked the rubidium incorporation that depends on
ATPase because of Na/K-ATPase inhibition. It is im-
portant to note that data from in vivo experiments
using higher ouabain concentrations killed the majorityely Coupled Plasma Optical Emission Spectrometer.
Figure 2 Inhibition of Rb+ incorporation in lung tissue by ouabain and OA. (A) Mice were divided into four groups. Lungs of mice from the
control group were perfused with Rb free-Hank’s. Mice lungs from the second group were perfused with KCl free-Hank’s solution. The third group
was perfused with KCl free-Hank’s plus ouabain and mice lungs from the 4th group were perfused with KCl free-Hank’s plus tris-oleate. Rb+
incorporation in lungs was measured after 15 min by ICP-OES in digested lung tissues. Results are expressed in μmol Rb+ incorporated per h per g of
wet tissue ± SEM of 5 to 13 animals in each group. (B) Calculated percent of ouabain sensitive inhibition of Na/K-ATPase based on data from
Figure 2A (the difference between Rb+ incorporation in absence and in presence of ouabain was considered as 100% enzyme activity). Ouabain
insensitive Rb+ incorporation represents the amount of Rb+ into the tissue that enters through potassium channels and passive diffusion. The
experiment was repeated twice. *P <0.002, compared to controls.
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urement can be assigned not only to an incomplete
tissue-washing procedure but also to a passive Rb+ in-
corporation through K+ channels.
The main advantage of the present modified method is
that it increases the sensitivity for Rb+ quantification: ru-
bidium incorporation was about 20 times higher than
seen in our previous work [16].
Inflammation induced by OA intravenous administra-
tion resembles ARDS in many morphological, histological
and physiological aspects [14]. In this regard, ARDS pa-
tients or at-risk patients who subsequently develop ARDS
have increased plasma OA concentrations [23]. Sepsis pa-
tients at risk to develop ARDS [24] present markedly in-
creased plasma OA levels compared to healthy volunteers
[25]. In most ARDS patients, the edema resolution and
Na/K-ATPase activity are impaired and patients havingreduced ability to clear edema have increased mortality
[6,26,27], suggesting that Na/K-ATPase is an important
player in the pathophysiology of ARDS [28]. Because of
the great importance of OA in several pathologies, we
decide to compare its effect on Na/K-ATPase activity
with the lung Na/K-ATPase inhibition caused by oua-
bain. Our previous report showed that the ouabain and
OA had similar in vivo effect on the Na/K-ATPase [16],
probably because we used higher OA doses. However,
Na/K-ATPase is not the sole target for OA. Since ouabain
was more effective in lung Na/K-ATPase inhibition than
OA, we suggest that OA should have additional targets in
cell membranes, such as fatty acid receptor and fatty acid
transporters [29-33].
It is worth to point out that, comparing with our pre-
vious communication [16], lung perfusion allows more
Rb+ to be incorporated in lung tissue. In the present
Gonçalves-de-Albuquerque et al. BMC Research Notes 2014, 7:798 Page 4 of 6
http://www.biomedcentral.com/1756-0500/7/798communication, as compared to our previous work, we
noted a higher sensitivity in Rb+ detection allowing
differential detection between oleic acid and ouabain on
Rb+ incorporation. The fact that OA can cause lung in-
jury with alveoli disruption has been well characterized
in animal models [34]. This could explain why lung injury
induced by OA is more severe than that one induced by
ouabain. Nevertheless, lung injury has an important cor-
relation with Na/K-ATPase inhibition [16].
Conclusions
This proposed assay is a reliable and powerful tool for
researchers to test the compounds targeting lung Na/K-
ATPase activity and, consequently, to study the impact
of Na/K-ATPase in lung physiology and pathology under
conditions similar to those found in the intact organ.
Methods
Animals
All experiments were conducted in male Swiss mice
(25 – 35 g) at age 6 to 10 weeks old obtained from the
Oswaldo Cruz Foundation breeding unit. The animals
were lodged at 22°C with a 12 h light/dark cycle and
free access to food and water. Animal housing condi-
tions and all experimental procedures conformed to in-
stitutional regulations and were in accordance with the
National Institute of Health guidelines on animal care.
The institutional animal welfare committee approved
all of the procedures described here under license num-
bers 002–08 and LW-36/10 (CEUA/FIOCRUZ).
Preparation of oleate solutions
OA (Sigma-Aldrich, St. Louis, MO) was used to prepare
a 100 mM tris-oleate solution as described in Gonçalves
de Albuquerque [35]. Briefly, after weighting and water
addition, sodium hydroxide was slowly added until the
pH reached 13.0. The solution was maintained at 37°C
and the mixture was sonicated until complete oleate
solubility. Then, the pH was carefully adjusted to 7.6
with dilute hydrochloric acid. The working oleate solu-
tion was prepared by appropriate dilutions of the
100 mM solution with sterile saline (PBS) pH 7.5. The
working oleate solutions were tested for the presence of
LPS by the limulus amebocyte lysate test (LAL), which
was provided by the Instituto Nacional de Controle de
Qualidade em Saúde (INCQS)-Fundação Oswaldo Cruz,
showing negative results.
Experimental design and ouabain and oleic acid perfusion
Mice were divided in four groups. We used 5 to 13 ani-
mals per group. The control group was perfused with Rb+
free-Hank’s solution. Each animal in the second group
was perfused with KCl free-Hank’s solution with Rb+. The
third group received the same KCl free-Hank’s with Rb+plusouabain, and finally the last group was perfused with
KCl free-Hank’s Rb+plus tris-oleate.
After complete anesthesia obtained by intraperitoneal
injection of 10 mg/kg of xylazin and 100 mg/Kg of keta-
min dissolved in sterile saline, the thoracic cavity was
opened and the left heart ventricle was cannulated using
a scalpel. At the same time, right atrial appendage was
cut and left open. The lung was covered with a piece of
gauze immersed in saline to prevent excessive water loss
by evaporation. The perfusion medium was a modified
Hank’s solution (pH 7.4) containing 136.9 mM NaCl,
5.4 mM RbCl, 0.8 mM MgSO4, 5 mM NaHCO3,
0.33 mM Na2HPO4, 0.44 mM NaH2- PO4, 5 mM Hepes,
1.5 mM CaCl2, 3 mM glucose and heparin (1000 UI/l)
both in the absence and in the presence of ouabain or
tris-oleate. The perfusion medium was continuously ox-
ygenated by bubbling a 95% O2, 5% CO2 gas mixture in
a homemade aerating chamber. Tubing carrying this
medium remained immersed in a temperature-regulated
water bath adjusted to maintain the perfused lung effluent
temperature at 36.5–37°C. The flow rate was 3 mL/min
based on our previous results with liver [11]. The flow rate
was regulated by an infusion pump (LifeMed model
LF2001, Life Med Ltd., Brazil). At the end of the perfusion,
physiological saline at 2–4°C was perfused at this same
flow rate.
Na/K-ATPase assay in mouse lungs based on Rb+
incorporation
After the rinsing procedure, the entire lung was re-
moved, rinsed with cold saline and gently dried with fil-
ter paper. Then, 0.5 g of the lung tissue was transferred
to glass tubes (250 mm × 22 mm) for digestion and
3 mL of 65% nitric acid was added. This mixture was
heated in a Tecnal apparatus (model TE040125. Tecnal
Ind., Brazil) at 100°C for 30 min – at this point some
H2O2 drops were added to increase the speed of tissue
digestion. The temperature was raised to 150°C for the
next 15 min, and then to 175°C for more 15 min and fi-
nally at 200°C until the digest was completely clear.
After cooling, the volume was adjusted to 15 mL with
distilled water. Digested tissue samples were used to
quantify Rb+ [11]. Briefly, for the rubidium assay we
used an iCAP 6300 dual view Inductively Coupled Plasma
Optical Emission Spectrometer (ICP OES) (Thermo
Scientific, Cambridge, England) equipped with a Mira
Mist nebulizer. Cyclonic spray chamber and a CCD de-
tector. The operational software iTEVA 2.0 was used to
data acquisition. All determinations were done in axial
view and using analytical curves with nine rubidium
standard solutions prepared by adequate dilution of
1,000 mg L−1 analytical grade Rb stock standard solution
(Quimlab Química & Metrologia®, Jardim Califórnia,
Jacareí, São Paulo, Brasil) until the desired concentrations
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(Merck Millipore, Billerica, Massachusetts, EUA). The lin-
earity of calibration curves was checked in the analytical
range 0.012–0.12 μmol/L, and was not tested beyond this
value. Samples having higher concentrations were diluted
and re-analyzed. Results were expressed as μmol of Rb+
incorporated per 30 min per gram of tissue.
Statistical analysis
Results were analyzed using “one way” ANOVA followed
by Newman-Keuls (software GraphPad Prism 5.0). Values
with p <0.05 were considered significant. Data are pre-
sented as mean ± SEM.
Abbreviations
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